Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Objective This study explored how different hospital volumes and surgeon volumes affect
thyroidectomy outcomes in terms of length of stay (LOS), costs, and in-hospital mortality …

Objectives: The goal of evidence-based practice guidelines is to optimize the management
of emerging diseases, such as differentiated thyroid cancer (DTC). The aim of this study was …

Abstract Background The 2015 American Thyroid Association endorsed less aggressive
management for low-risk papillary thyroid cancer (LR-PTC). We aimed to identify factors …

Context: Little is known about practice patterns in thyroid cancer, a cancer that is increasing
in incidence. Objective: We sought to identify aspects of thyroid cancer management that …

RESULTS Of disease-free patients, 31.6% were classified as minimizers, 42.5% as
moderate maximizers, and 25.9% as strong maximizers. In the past year, 25.2%, 27.3%, and …

A remarkable, evidence-based trend toward de-escalation has reformed the practice of
radioactive iodine (RAI) administration for thyroid cancer patients. Updated guidelines have …

Context Routine radioactive iodine (RAI) ablation for low-risk differentiated thyroid cancer
(DTC) is not supported by current practice guidelines. Objective To assess recent stage …

Context The use of radioactive iodine (RAI) for low-risk thyroid cancer is common, and
variation in its use exists, despite the lack of benefit for low-risk disease and potential harms …

Recent modifications in the management of well‐differentiated thyroid cancer have resulted
in significant alterations in clinical approach. Utilizing a series of preoperative and …